Jamie Smith
Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 722-553573
Gothenburg, Sweden. 12 November 2025. Mölnlycke Health Care, a global leader in MedTech, is the first company to donate a patent to SKF’s groundbreaking digital platform, The Patent Bay – taking bold action to harness collaboration and accelerate innovation in sustainable healthcare.

“We are proud to be part of this pioneering initiative,” says Zlatko Rihter, CEO of Mölnlycke Health Care. “Our purpose is to revolutionise care for people and planet. Supporting The Patent Bay is a powerful way to help turn that purpose into action.”
Today’s healthcare systems are under immense pressure to deliver the right care to the right patients, often with fewer resources. Mölnlycke believes that embracing partnerships, collaboration and openness are key to overcoming these challenges. By contributing to The Patent Bay, Mölnlycke is helping unlock new opportunities to help shape more sustainable healthcare systems for the future.
Mölnlycke is sharing a patent family relating to a method to determine a patient’s risk score. The innovation uses patient data to help caregivers predict risks and tailor treatments more effectively. By comparing a patient’s health profile to large-scale models, the patented method may improve treatment accuracy, reduce unnecessary interventions and lower healthcare costs.
Mölnlycke is making its patent freely accessible to innovators, entrepreneurs, researchers and healthcare providers worldwide, with the ultimate aim to improve patient outcomes.
“The Patent Bay was founded to accelerate progress through open knowledge and shared innovation. Mölnlycke Health Care’s decision to share smarter patient risk scoring highlights the power of collaboration—enabling better care and advancing healthcare for all. It’s a clear reminder that sharing drives meaningful progress for people, society and the planet,” says Annika Ölme, CTO and Senior Vice President, Technology Development at SKF.
Zlatko Rihter adds, “We encourage other organisations to join us in contributing to The Patent Bay to help drive open innovation for a more sustainable future.”
For more information please contact:

Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 722-553573
Note to editors
About The Patent Bay
The Patent Bay is a unique platform for sharing patents related to sustainable development, free of charge. It aims to accelerate technologies with the potential to advance sustainability through openness and collaboration. By taking a new approach to industrial innovation and rethinking how it is shared, it removes traditional barriers around patents – making sustainable technologies freely accessible, without the complex licensing or governance structures that often slow collaboration. The initiative reflects a shift from ownership to openness, and represents a practical, collaborative approach to industrial responsibility in the climate era. thepatentbay.com
Mölnlycke has completed construction of its first manufacturing facility in China, marking a major milestone in the company's growth journey and strengthening its ability to serve one of the world's largest and fastest growing healthcare markets.
Peachtree Corners, GA. 7 July, 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, has launched three product innovations in the U.S. since the start of 2026. Designed to expand access to advanced wound care solutions and strengthen the company’s U.S. presence, the portfolio expansion also supports long-term value creation across key market segments.
Gothenburg, Sweden. 23 June 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, today announces changes to its Board of Directors. Christian Cederholm will leave his Board assignment, while Filippa Stenberg will take his place as member of the Board. Thomas Kidane will step in as deputy board member.
Gothenburg, Sweden. 8 June 2026. Mölnlycke Health Care (“Mölnlycke®”), a global leader in MedTech, today confirmed a combined investment of approximately EUR 40 million in Mikkeli, Finland, and Oldham, UK. The investments strengthen the company’s global wound care manufacturing network by increasing capacity, optimising process quality and enhancing supply chain resilience and sustainability.
Gothenburg, Sweden, and Shanghai, China. 21 May 2026.
Mölnlycke Health Care (“Mölnlycke®”), a global leader in MedTech and advanced wound care solutions, and Zhende Medical, a leading supplier of medical care and protection in China, today announce the formation of a new joint venture company in China to accelerate growth in one of the world’s fastest-growing wound care markets. The joint venture, majority-owned by Mölnlycke, will integrate the two companies’ wound care portfolios and commercial capabilities to offer healthcare providers, patients and the public expanded access to advanced treatments, improved care delivery and better patient outcomes across China.
Gothenburg, Sweden. 27 April 2026. A new study1 published in the Journal of Hospital Infection shows that introducing a simple glove change during caesarean birth could deliver millions in cost savings for the National Health Service (NHS) in England.
Gothenburg, Sweden. Wednesday 15 April 2026. Mölnlycke Health Care announces today the appointment of Andreas Johansson as Interim Chief Financial Officer (CFO), with immediate effect.
Gothenburg, Sweden. 1 April 2026. Today, Mölnlycke Health Care has published its annual report 2025, including sustainability report, outlining the company’s continued focus on revolutionising care for people and planet.